Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.

Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME, Furlong CE, Brown RH Jr.

Neurology. 2008 Mar 18;70(12):929-34. doi: 10.1212/01.wnl.0000305956.37931.dd.

PMID:
18347314
[PubMed - indexed for MEDLINE]
2.

Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases.

Androutsopoulos VP, Kanavouras K, Tsatsakis AM.

Toxicol Appl Pharmacol. 2011 Nov 1;256(3):418-24. doi: 10.1016/j.taap.2011.08.009. Epub 2011 Aug 12. Review.

PMID:
21864557
[PubMed - indexed for MEDLINE]
3.

Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.

Costa LG, Cole TB, Vitalone A, Furlong CE.

Clin Chim Acta. 2005 Feb;352(1-2):37-47. Review.

PMID:
15653099
[PubMed - indexed for MEDLINE]
4.

Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.

Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE.

Biomarkers. 2003 Jan-Feb;8(1):1-12. Review.

PMID:
12519632
[PubMed - indexed for MEDLINE]
5.

The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.

Costa LG, Li WF, Richter RJ, Shih DM, Lusis A, Furlong CE.

Chem Biol Interact. 1999 May 14;119-120:429-38. Review.

PMID:
10421480
[PubMed - indexed for MEDLINE]
6.
7.

Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.

Deakin SP, James RW.

Clin Sci (Lond). 2004 Nov;107(5):435-47. Review.

PMID:
15265000
[PubMed - indexed for MEDLINE]
Free Article
8.

Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.

Furlong CE.

J Biochem Mol Toxicol. 2007;21(4):197-205. Review. Erratum in: J Biochem Mol Toxicol. 2007;21(5):323.

PMID:
17936934
[PubMed - indexed for MEDLINE]
9.

Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.

Costa LG, Cole TB, Furlong CE.

J Toxicol Clin Toxicol. 2003;41(1):37-45. Review.

PMID:
12645966
[PubMed - indexed for MEDLINE]
10.

PON1 Q192R and L55M polymorphisms and organophosphate toxicity risk: a meta-analysis.

You T, Lv J, Zhou L.

DNA Cell Biol. 2013 May;32(5):252-9. doi: 10.1089/dna.2012.1961. Epub 2013 Apr 16. Review.

PMID:
23590198
[PubMed - indexed for MEDLINE]
11.

Modulation of paraoxonase (PON1) activity.

Costa LG, Vitalone A, Cole TB, Furlong CE.

Biochem Pharmacol. 2005 Feb 15;69(4):541-50. Review.

PMID:
15670573
[PubMed - indexed for MEDLINE]
12.

Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

Mackness M, Mackness B.

Free Radic Biol Med. 2004 Nov 1;37(9):1317-23. Review.

PMID:
15454272
[PubMed - indexed for MEDLINE]
13.

Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Costa LG, Giordano G, Cole TB, Marsillach J, Furlong CE.

Toxicology. 2013 May 10;307:115-22. doi: 10.1016/j.tox.2012.07.011. Epub 2012 Jul 31. Review.

PMID:
22884923
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The paraoxonase gene family and atherosclerosis.

Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST.

Free Radic Biol Med. 2005 Jan 15;38(2):153-63. Review.

PMID:
15607899
[PubMed - indexed for MEDLINE]
15.

Determinants of paraoxonase 1 status: genes, drugs and nutrition.

Schrader C, Rimbach G.

Curr Med Chem. 2011;18(36):5624-43. Review.

PMID:
22172068
[PubMed - indexed for MEDLINE]
16.

[Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].

Josse D, Masson P.

Ann Pharm Fr. 2001 Apr;59(2):108-18. Review. French.

PMID:
11320335
[PubMed - indexed for MEDLINE]
17.

Paraoxonase 1 status as a risk factor for disease or exposure.

Richter RJ, Jarvik GP, Furlong CE.

Adv Exp Med Biol. 2010;660:29-35. doi: 10.1007/978-1-60761-350-3_4. Review.

PMID:
20221868
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.

Valiyaveettil M, Alamneh YA, Doctor BP, Nambiar MP.

Toxicol Lett. 2012 Apr 5;210(1):87-94. doi: 10.1016/j.toxlet.2012.01.013. Epub 2012 Jan 25. Review.

PMID:
22301377
[PubMed - indexed for MEDLINE]
19.

Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.

Furlong CE, Cole TB, Jarvik GP, Pettan-Brewer C, Geiss GK, Richter RJ, Shih DM, Tward AD, Lusis AJ, Costa LG.

Neurotoxicology. 2005 Aug;26(4):651-9. Review.

PMID:
16112327
[PubMed - indexed for MEDLINE]
20.

Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism.

Costa LG, Cole TB, Jarvik GP, Furlong CE.

Annu Rev Med. 2003;54:371-92. Epub 2001 Dec 3. Review.

PMID:
12525679
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk